Adtech Pharma, Inc.

With scientific innovation, fulfill medical needs and build shareholder value

Company Overview

Seasoned principals with pharma expertise and track record of successful drug development and launch

Capital efficient strategy

High Value Asset

Addresses the disease condition with a novel mechanism of action

Platform technology for additional indications

Patent protection available through 2040’s

Indications

Scientifically proven efficacy and safety

For patients not responding to current therapies

Sizable disease prevalence worldwide

Regulatory Pathway

US 502(b)(2) approval pathway

Novel formulations with new IP

Breakthrough mechanism of action

GLAUCOMA LEADS TO BLINDNESS IF UNTREATED

Learn More